Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Favorable pharmacokinetics and pharmacodynamics reported for insulin aspart at FIP '99

Sep. 8, 1999

Novel pyridine and pyrimidine derivatives from Amgen particularly useful for obesity Rx

Sep. 8, 1999

Dr. Reddy performs SAR studies in the area of antidiabetic/hypolipidemic thiazolidinediones

Sep. 7, 1999

PTP1B inhibitors evaluated at Wyeth-Ayerst for potential as oral antidiabetic agents

Sep. 6, 1999

Regeneron provides interim data from phase I Axokine study and highlights further plans

Sep. 6, 1999

OSI establishes partnership with Tanabe Seiyaku for diabetes treatment

Sep. 6, 1999

Genzyme General and Genovo to collaborate on gene therapy for rare genetic diseases

Sep. 6, 1999

Exocell receives patents for diabetic kidney disease therapy

Sep. 3, 1999

Hemopure receives fast track status in South Africa

Sep. 3, 1999

Hydrazone derivatives from Novo Nordisk useful for normalizing glucose levels

Sep. 2, 1999

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...